NantHealth, which has designed genomic and protein-based molecular diagnostic testing services to support personalized cancer treatment, and recently aligned with software vendor Allscripts, has bought the commercial Healthcare Solutions unit of Harris Corporation.

Terms of the acquisition, the largest yet for NantHealth, were not disclosed. The deal does not include Harris’ numerous healthcare services contracts with the federal government.

Also See: Critical to HIE Success, Payers Still Lag

The acquired Harris Healthcare Solutions unit sells the FusionFx interoperability and health information exchange platform. In addition to the HIE, its products include a provider portal, patient portal, and referral management and secure messaging software.

Allscripts and NantHealth recently invested in each other, deepening a commitment to bring personalized medicine to the point of care, particularly for cancer treatment. The financial investments build on a partnership first reported in March, as the companies pursue a strategy to develop an integrated, evidence-based, personalized approach to treating patients, initially focusing on cancer care.

NantHealth is backed by Patrick Soon-Shiung, MD, a Los Angeles billionaire. In early July, Allscripts invested $200 million in cash to buy a 10 percent equity stake in NantHealth. NantCapital LLC, the personal investment vehicle of Soon-Shiung, made a $100 million investment in Allscripts through a private placement of common stock. Allscripts sells electronic health records and practice management software, as well as its own health information exchange product, dbMotion.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access